SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...
Outset Medical Inc. investors can’t proceed with securities fraud claims over most of the company’s statements about its ...
Trace Medical & Outset Medical sign long-term distribution agreement for Tablo ® Hemodialysis System
WHITMORE LAKE, Mich.--(BUSINESS WIRE)--Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical ...
Please provide your email address to receive an email when new articles are posted on . Outset Medical halts sales of medical cart to obtain FDA 510(k) approval. The company released its ...
About a year after the company’s last distribution hold wrapped up, Outset Medical is once again pausing shipments of a component of its Tablo hemodialysis systems. This time around, the hold is ...
SAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first organization to establish a home hemodialysis program, today announced a collaboration with Outset Medical, Inc ...
Please provide your email address to receive an email when new articles are posted on . Outset Medical Inc. reported in a recent 8-K filing that it had received a warning letter from the FDA ...
A class action lawsuit was filed against Outset Medical (OM) by Levi & Korsinsky on August 29, 2024. The plaintiffs (shareholders) alleged that they bought OM stock at artificially inflated prices ...
Outset assumes no obligation to update these statements. For a list and description of risks and uncertainties associated with our business, please refer to the Risk Factors section of Outset’s public ...
In its Q2 earnings release, Outset Medical Inc OM announced it has paused the shipment of TabloCart with Prefiltration, an accessory for the Tablo System, pending the FDA's clearance of a 510(k) the ...
Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research ...
Outset Medical, Inc. announced that it will release its financial results for the first quarter of 2025 on May 7, 2025, after market close. The company's Chair and CEO, Leslie Trigg, along with CFO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results